New Data Analyses from Phase 3 Study of Investigational Gene Therapy Nadofaragene Firadenovec Presented at Society of Urologic Oncology Annual Meeting
December 02, 2020 10:03 ET
|
FerGene Inc.
CAMBRIDGE, Mass, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Low rate of cystectomy and delayed time to cystectomy among patients who achieved complete responsePatient characteristics or prior treatment...